98-15556. Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 112 (Thursday, June 11, 1998)]
    [Notices]
    [Page 32014]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-15556]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Circulatory System Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Circulatory System Devices Panel of the Medical 
    Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on June 29 and 30, 1998, 8 
    a.m. to 5 p.m.
        Location: Corporate Bldg., conference room 020B, 9200 Corporate 
    Blvd., Rockville, MD.
        Contact Person: John E. Stuhlmuller, Center for Devices and 
    Radiological Health (HFZ-450), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-443-8243, ext. 157, or FDA 
    Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
    the Washington, DC area), code 12625. Please call the Information Line 
    for up-to-date information on this meeting.
        Agenda: On June 29, 1998, the committee will discuss, make 
    recommendations, and vote on a premarket approval application for an 
    external compression device used in cardiopulmonary resuscitation. On 
    June 30, 1998, the committee will discuss and make recommendations on 
    permanent cardiovascular implants such as heart valves and vascular 
    grafts.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by June 18, 1998. 
    Oral presentations from the public will be scheduled between 
    approximately 8 a.m. and 8:30 a.m. on June 29 and 30, 1998. Near the 
    end of committee deliberations on both days, a 30-minute open public 
    session will be conducted to address issues specific to the submission 
    or topic before the committee. Time allotted for each presentation may 
    be limited. Those desiring to make formal oral presentations should 
    notify the contact person before June 18, 1998, and submit a brief 
    statement of the general nature of the evidence or arguments they wish 
    to present, the names and addresses of proposed participants, and an 
    indication of the approximate time requested to make their 
    presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: June 4, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-15556 Filed 6-10-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/11/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-15556
Pages:
32014-32014 (1 pages)
PDF File:
98-15556.pdf